Michael Collins, CMA, is a highly experienced finance professional currently serving as Senior Director of Global Pricing for Retinal Gene Therapy, CAR-T, and Oncology Hematology at Johnson & Johnson since April 2023. Prior to this role, Collins held various leadership positions at The Janssen Pharmaceutical Companies of Johnson & Johnson, including Director of Global Pricing, where responsibilities encompassed developing pricing strategies for complex therapeutic areas, implementing innovative payment models, and conducting extensive market research. With a background spanning multiple roles in commercial finance and pricing strategy, Collins has successfully driven financial leadership and strategy development for major drug launches across various therapeutic sectors. Education was completed at The College of New Jersey from 2000 to 2004.
This person is not in any teams
This person is not in any offices